Clinical Trials Sponsored by Stallergenes laboratories

Total 2253 results

Mekos Laboratories AS

Completed

Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate

Allergic Contact Dermatitis

Denmark
Rovi Pharmaceuticals Laboratories

Recruiting

Evaluation of the Pharmacokinetics, Safety, and Tolerability of IM Letrozole LEBE in Healthy Post-menopausal Women (LEILA-1)

Healthy

Czechia
Rovi Pharmaceuticals Laboratories

Recruiting

Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse (RESHAPE)

Schizophrenia

Germany
Romark Laboratories L.C.

Not yet recruiting

Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness

COVID-19
Dot Laboratories, Inc.

Recruiting

The EMPOWER Study: Endometriosis Diagnosis Using microRNA (EMPOWER)

Endometriosis

United States
Bühlmann Laboratories AG

Recruiting

BÜHLMANN fPELA in the Diagnosis of Exocrine Pancreatic Insufficiency

Exocrine Pancreatic Insufficiency

Germany
Fresh Medical Laboratories

Recruiting

Establish ProLung Test Measurement Collection Protocol for Future Studies.

Cancer , Healthy

United States
Wren Laboratories LLC

Active, not recruiting

Surgical Intervention and the NETest (NETest_Sx)

Neuroendocrine Tumor | Gastroenteropancreatic

Italy
Rovi Pharmaceuticals Laboratories

Completed

Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths (PRISMA-1)

Schizophrenia | Schizoaffective Disorder

Spain, South Africa, Russian Federation, Croatia
Romark Laboratories L.C.

Completed

Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

Influenza

United States
Neuvosyn Laboratories, LLC

Enrolling by invitation

A Study Evaluation the Safety and Efficacy of Hormone Replacement Therapy With North Star Compared to Levothyroxine in Patients With Primary Hypothyroidism

Hypothyroidism

United States
Charleston Laboratories, Inc

Completed

A Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg for Acute Pain and the Prevention of OINV

Pain | Nausea | Vomiting

United States
Romark Laboratories L.C.

Completed

A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza

Influenza

United States, Australia, Puerto Rico
Aponia Laboratories, Inc.

Completed

Controlled Study to Assess the Efficacy and Safety of S-Ibuprofen Topical Gel 5% (AP0302) in the Treatment of DOMS

Pain, Acute

United States
Starkey Laboratories, Inc

Completed

Speech Intelligibility in Quiet and Noise for New vs. Legacy Hearing Aids

Hearing Loss | Hearing Loss, Sensorineural

United States
Rovi Pharmaceuticals Laboratories

Completed

Comparative Bioavailability of Risperidone.

Schizophrenia

United States
Rovi Pharmaceuticals Laboratories

Completed

Comparative Bioavailability of Risperidone

Schizophrenia

United States
Nova Laboratories Limited

Completed

Oral Liquid 13-cis-retinoic Acid (13-CRA) (My-CRA)

Neuroblastoma

United Kingdom
Impax Laboratories, LLC

Completed

A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).

Parkinson's Disease

United States, Canada, France, Germany, Poland, Romania, Spain, Ukraine
Impax Laboratories, LLC

Completed

An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease

Parkinson's Disease

United States, Canada, Estonia, Latvia, Lithuania, Romania, Ukraine, Germany, Poland, Spain
Impax Laboratories, LLC

Completed

A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease

Parkinson's Disease

United States
Impax Laboratories, LLC

Completed

A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease (APEX-PD)

Parkinson's Disease

United States, Canada, Estonia, Latvia, Lithuania, Romania, Ukraine
Fresh Medical Laboratories

Completed

The Effects of Sex, Body Mass Index, Day-to-Day Subject Variability for the ProLung Test and Variability of a Single Device When Volume-Averaged Thoracic Bioconductance is Measured With the ProLung Test

Healthy Volunteers
Advenchen Laboratories, LLC

Terminated

Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001) (AL3818)

Cervical Cancer | Ovarian Cancer | Endometrial Cancer

United States
Ferndale Laboratories, Inc.

Completed

A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis

Plaque Psoriasis

United States
Romark Laboratories L.C.

Terminated

Study of Nitazoxanide in Adults With Acute Uncomplicated Influenza

Influenza

United States
Romark Laboratories L.C.

Completed

Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

Influenza

United States, Australia, Belgium, Canada, New Zealand
Pfizer
Forest Laboratories

Completed

Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal Infections

Complicated Intra-Abdominal Infection

United States, Croatia, Bulgaria, Peru, Russian Federation, Latvia, Ukraine, Mexico, Romania, South Africa, Argentina, Czechia, Hungary, Israel, Taiwan, India, Thailand, Spain, Netherlands, Malaysia
Pfizer
Forest Laboratories

Completed

Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)

Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis

Croatia, Brazil, Bulgaria, Korea, Republic of, Russian Federation, Hungary, Poland, Romania, Ukraine, Argentina, Israel, Portugal, Greece, Taiwan, Japan, Slovakia, Serbia, United States, Mexico, Germany, Turkey, Czechia
Pfizer
Forest Laboratories

Completed

A Study to Assess the Levels of CAZ-AVI and Metronidazole in the Blood When Given Together and Separately

Healthy

United States
Charleston Laboratories, Inc

Completed

A Multi-Center Actual-Use Study on the Safety of CL 108 for the Treatment of Moderate to Severe Acute Pain Associated With Osteoarthritis of the Knee or Hip

Pain | Nausea | Vomiting

United States
MedMira Laboratories Inc.

Completed

Clinical Performance of Reveal G4 Rapid HIV-1 Antibody Test

HIV Infections

United States
Antigen Laboratories, Inc.

Withdrawn

Phase 2 Study in Adults Sensitized to Short Ragweed

Allergic Rhinitis
Paddock Laboratories, Inc.

Completed

A Relative Bioavailability Study of Moexipril HCl 15 mg Tablets Under Fasting Conditions

Healthy

United States
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions

Fasting

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions

Fed

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed Condition

Fasting

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions

Fed

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fasting Condition

Fasting

India
Watson Laboratories, Inc.

Completed

Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris

Acne Vulgaris
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed Condition

Fed

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fasting Condition

Fasting State

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Indomethacin Extended-Release Capsules 75 mg Under Fed Condition

Fed

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fed Condition

Fed

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Allopurinol 300 mg Tablets USP Under Fasting Condition

Fasting State

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fasting Condition

Fasting State

India
Forest Laboratories
PPD

Terminated

Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI (ASPECT2)

Coronary Artery Disease

United States, Argentina, Belgium, Brazil, Netherlands
Forest Laboratories
Phenomix

Terminated

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone

Diabetes Mellitus, Type II

United States, Belarus, India, Romania, Germany, Lithuania
Ferndale Laboratories, Inc.

Completed

LMX-4 for Postoperative Pain Management in Infants and Children Undergoing Penoplasty Surgery (LMX-4)

Post-Operative Pain

United States
Rovi Pharmaceuticals Laboratories

Completed

Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of a New Ultra Low Molecular Weight Heparin (RO-14) Administered Subcutaneously Increasing Single-doses to Healthy Male Volunteers

Healthy

Spain

3

Subscribe